2-Amino-4-aryl thiazole: a promising scaffold identified as a potent 5-LOX inhibitor
Author:
Affiliation:
1. Department of Biotechnology
2. Indian Institute of Technology
3. Madras
4. India
5. Department of Chemistry
6. Vellore Institute of Technology
7. Vellore
Abstract
Human 5-lipoxygenase (5-LOX) is a target for asthma and allergy treatment. Zileuton is the only marketed drug targeting this enzyme (IC50 ∼ 1 μM). The current study identifies a promising lead molecule which could be improved to match the activity of zileuton.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2016/RA/C5RA28187C
Reference60 articles.
1. W.H.O. data sheet, 2012, http://www.who.int
2. Corticosteroids: the mainstay in asthma therapy
3. Leukocyte navigation mechanisms as targets in airway diseases
4. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-01-30
2. IN VITRO5-LOX INHIBITORY POTENTIAL AND ANTIOXIDANT ACTIVITY OF NEW ISOXAZOLE DERIVATIVES;2024-01-08
3. Evaluating the inhibitory activity of ferrocenyl Schiff bases derivatives on 5-lipoxygenase: Computational and biological studies;Journal of Inorganic Biochemistry;2023-08
4. Thiazole, isatin and phthalimide derivatives tested in vivo against cancer models: a literature review of the last six years;Current Medicinal Chemistry;2023-04-26
5. Potential of pyrroquinazoline alkaloids from Adhatoda vasica Nees. as inhibitors of 5-LOX – a computational and an in-vitro study;Journal of Biomolecular Structure and Dynamics;2020-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3